← Back to All Filings

Medpace Holdings Officer Stephen P. Ewald Files Form 144 to Sell $859K in Stock

Low SignificanceOctober 29, 2026 at 4:55:20 PM EDT

Medpace Holdings, Inc.

$MEDP144CIK: 0001668397

Subscribe to track MEDP

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Form 144 Notice of Proposed Sale: Medpace Holdings, Inc. ($MEDP) • Insider: Stephen P. Ewald (Officer) • Shares Proposed to Sell: 1,245 • Estimated Total Value: $859,050.00 (~$690.00/share) • Approximate Sale Date: 10/29/2026 • Broker: Fidelity Brokerage Services LLC • Acquisition History: Acquired on 10/27/2025 via Stock Option Exercise

Comprehensive Analysis

Overview

On October 29, 2026, Stephen P. Ewald, an Officer of Medpace Holdings, Inc. ($MEDP), submitted a Form 144 notice disclosing an intention to sell 1,245 shares of Common Stock with an estimated aggregate market value of $859,050.00.

Transaction Details

  • Securities to Sell: 1,245 Common shares
  • Approximate Sale Date: October 29, 2026
  • Aggregate Market Value: $859,050.00 (implied price of ~$690.00 per share)
  • Shares Outstanding: 27,971,686 shares (the planned sale constitutes <0.01% of outstanding shares)
  • Origin of Shares: Acquired on October 27, 2025, via a stock option exercise from the issuer paid in cash
  • Broker: Fidelity Brokerage Services LLC

Significance & Market Impact

The trading significance is rated Low. The proposed transaction represents an immaterial fraction of Medpace's total outstanding equity and follows the standard monetization pattern of stock options held for one year.

Topics:#MEDP#Medpace#Form144#InsiderSelling#StockOptions

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.